{"id":861465,"date":"2025-06-17T13:38:08","date_gmt":"2025-06-17T17:38:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/"},"modified":"2025-06-17T13:38:08","modified_gmt":"2025-06-17T17:38:08","slug":"dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/","title":{"rendered":"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN"},"content":{"rendered":"

<\/p>\n

Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE<\/a>)–The DJS Law Group<\/a> announces that it is investigating claims on behalf of investors of Dyne Therapeutics (\u201cDyne\u201d or \u201cthe Company\u201d) (NASDAQ: DYN<\/a>) for violations of the securities laws.<\/p>\n

INVESTIGATION DETAILS: <\/b>The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Dyne announced in a June 17, 2025, press release that, \u201cBased on feedback from the FDA, along with our 6-month and new 12-month efficacy data, we have submitted a revised protocol for the ongoing Registrational Expansion Cohort of the ACHIEVE trial with vHOT as the primary endpoint for potential Accelerated Approval.\u201d Based on this news, shares of Dyne fell by more than 19.4% in intraday trading on the same day.<\/p>\n

\nIf you are a shareholder who suffered a loss, contact us to participate<\/a>.<\/p>\n

WHY DJS LAW GROUP?<\/b> DJS Law Group\u2019s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic\/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.<\/p>\n

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250617705620\/en\/<\/a><\/span><\/p>\n

\nDavid J. Schwartz
\n
DJS Law Group
\n
274 White Plains Road, Suite 1
\n
Eastchester, NY 10709
\n
Phone: 914-206-9742
\n
Email: David@djslawllp.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Class Action Lawsuit Professional Services Legal<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Dyne Therapeutics (\u201cDyne\u201d or \u201cthe Company\u201d) (NASDAQ: DYN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Dyne announced in a June 17, 2025, press release that, \u201cBased on feedback from the FDA, along with our 6-month and new 12-month efficacy data, we have submitted a revised protocol for the ongoing Registrational Expansion Cohort of the ACHIEVE trial with vHOT as the primary endpoint for potential Accelerated … <\/p>\n

Continue reading “Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-861465","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Dyne Therapeutics (\u201cDyne\u201d or \u201cthe Company\u201d) (NASDAQ: DYN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Dyne announced in a June 17, 2025, press release that, \u201cBased on feedback from the FDA, along with our 6-month and new 12-month efficacy data, we have submitted a revised protocol for the ongoing Registrational Expansion Cohort of the ACHIEVE trial with vHOT as the primary endpoint for potential Accelerated … Continue reading "Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-17T17:38:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN\",\"datePublished\":\"2025-06-17T17:38:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/\"},\"wordCount\":308,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/\",\"name\":\"Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-06-17T17:38:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/","og_locale":"en_US","og_type":"article","og_title":"Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk","og_description":"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group announces that it is investigating claims on behalf of investors of Dyne Therapeutics (\u201cDyne\u201d or \u201cthe Company\u201d) (NASDAQ: DYN) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and\/or failed to disclose information pertinent to investors. Dyne announced in a June 17, 2025, press release that, \u201cBased on feedback from the FDA, along with our 6-month and new 12-month efficacy data, we have submitted a revised protocol for the ongoing Registrational Expansion Cohort of the ACHIEVE trial with vHOT as the primary endpoint for potential Accelerated … Continue reading \"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-17T17:38:08+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN","datePublished":"2025-06-17T17:38:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/"},"wordCount":308,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/","name":"Dyne Therapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights \u2013 DYN - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-06-17T17:38:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250617705620r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyne-therapeutics-investigated-for-securities-fraud-violations-contact-the-djs-law-group-to-discuss-your-rights-dyn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dyne Therapeutics Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights \u2013 DYN"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/861465","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=861465"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/861465\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=861465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=861465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=861465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}